Gemcitabine belongs to class of anti cancer drugs called as antineoplastics. It fights against the growth of cancer cells which eventually results in their lysis.
Gemcitabine possesses the potent anti tumor activity which is used in the treatment of various types of bladder cancer, lung cancer, breast cancer and cancer of pancreas.
Tell your doctor if you have any allergic reaction to gemcitabine, kidney disease, liver disease (especially cirrhosis), a history of alcoholism, receiving radiation treatment. In addition, discuss with your doctor about your pregnancy or planning to become pregnant.
This medicine is contraindicated if you have any hypersensitivity to this medicine, myelosuppression, renal impairment or hepatic impairment etc.
Seek medical attention if you have any of these adverse effects: nausea, upper stomach pain, itching, loss of appetite, dark urine, difficulty in breathing clay-colored stools, jaundice, chest pain or pain radiating to the arm or shoulder, nausea, sweating, hives, difficult breathing, swelling of your face, lips, tongue, or throat, pale skin, easy bruising or bleeding, unusual weakness, urinating less than usual or not at all.
Epirubicin injection has strong anti tumor action by interfering with the synthesis and function of DNA. The given injection is used to treat cancers of breast, lungs, ovaries, lymph system and stomach. Epirubicin is an antineoplastic in the anthracycline class which prevents abnormal growth of tissues.
This injection is to be administered only under the supervision of your doctor. Epirubicin should be injected slowly into a vein. Do not inject into a muscle or under the skin. If this medication by coincidence leaks into the skin/muscle around the injection site, it may cause serious damage. Tell your doctor without delay if you observe redness, pain or swelling at or near the injection site.
Use of this medicine should be avoided in those are allergic to epirubicin or to any of the ingredients of the medication, allergic to other anthracycline-type medications like doxorubicin, breast-feeding, recent heart attack, heart failure, irregular heart rhythm, severe heart disease, severe liver impairment.
Epirubicin forms a complex with DNA by intercalation of its planar rings between nucleotide base pairs, with consequent inhibition of nucleic acid (DNA and RNA) and protein synthesis.Such intercalation triggers DNA cleavage by topoisomerase II, resulting in cytocidal activity. Epirubicin also inhibits DNA helicase activity, preventing the enzymatic separation of double-stranded DNA and interfering with replication and transcription
With an aim to fulfill diverse requirements of clients, we are engaged in providing superior quality Mesna Injection. Extensively demanded at hospitals, clinics and health care centers, the offered injection is given to the patients suffering from cancer. It helps to protect bladder lining from ifosfamide. This injection is formulated by a team of experienced professionals with the use of accurate chemical composition and advanced methodology. Apart from this, the provided Mesna Injection is available in airtight packaging to retain its purity level and shelf life.
Key points:Fast response towards cancer cells Hygienically processed
Category: Chemoprotectant/Cytoprotective Agent/ Antidotes
Composition- : Each ml contains: Mesna 100mg Water for Injection q.s.
Mesna is used to reduce the incidence of ifosfamide-induced hemorrhagic cystitis. Mesna disulfide is reduced to the free thiol compound, mesna, which reacts chemically with the urotoxic ifosfamide metabolites, resulting in their detoxification.
|Specification-|| pH range : 4.5 to 7.0
Mesna Injection is a detoxing agent to inhibit the hemorrhagic cystitis induced by ifosfamide. It is a sterile, nonpyrogenic, aqueous solution of clear and colorless to light pink appearance in clear glass multidose vials for intravenous administration. It is used to prevent bleeding from the bladder during ifosfamide or cyclophosphamide chemotherapy.
|Indication :||Prevention of toxicity to the urinary passage caused by cyclophosphamide or Trofosfamide.|
|Dosage :-||I.V. 20% of the dose of anti-neoplastic on weight basis, over 15-30 minutes at 4 hours interval|
|Precautions:-|| Tell your doctor and pharmacist if you are allergic to mesna or any other drugs.
Tell your doctor and pharmacist what prescription and nonprescription medications you are taking, including vitamins.
Tell your doctor if you have or have ever had liver or kidney disease.
Tell your doctor if you are pregnant or breast-feeding. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy.
Do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.
|Drug interaction:||Mercaptopurine, Cyclophosphamide, Digoxin.|
|Adverse Effect-:||G.I. Disturbance, headache, skin rash, tachycardia, hypotension|
|Storage:||After preparation, this medication is stable for 24 hours at 77 degrees F (25 degrees C). Before preparation, store the vials at room temperature between 59 and 86 degrees F (15-30 degrees )|
We are an entity of proficient professionals, devoted to offering best health care services for mankind. Our Cisplatin Injection is a potent treatment against cancer. The injection is manufactured using high grade chemicals under the guidance of adroit specialized at the advanced processing unit.
Cisplatin belongs to the group of medications called as antineoplastics, and particularly to the group of antineoplastics known as platinum-containing compounds. Cisplatin hinders the growth of cancer cells by interfering with the genetic material DNA, which is vital for cells multiplication. It is used to treat cancer of the bladder, ovaries, testicles, head and neck.
Before starting treatment with Cisplatin, tell your doctor about ongoing prescribed medications or any non prescribed medications (vitamins, herbal remedies etc).
Cisplatin is contraindicated in patients with a history of allergic reactions to Cisplatin or other platinum containing compounds, pre-existing renal impairment, myelosuppressed patients or in patients with hearing impairment.
This medicine should not be used if you are pregnant, planning for pregnancy or breastfeeding. Tell your doctor if you have become pregnant while receiving Cisplatin as it may harm the fetus.
Seek immediate medical attention if you observe signs of an allergic reaction, breathing difficulty, numbness, tingling, swelling of your face, lips, tongue or throat.